Epidemiology and management of essential tremor in children.
Identifieur interne : 000849 ( Main/Exploration ); précédent : 000848; suivant : 000850Epidemiology and management of essential tremor in children.
Auteurs : Joseph Ferrara [États-Unis] ; Joseph Jankovic [États-Unis]Source :
- Paediatric drugs [ 1174-5878 ] ; 2009.
English descriptors
- KwdEn :
- Adolescent, Adrenergic beta-Antagonists (therapeutic use), Adult, Aged, Animals, Child, Clinical Trials as Topic, Diagnosis, Differential, Essential Tremor (drug therapy), Essential Tremor (epidemiology), Essential Tremor (physiopathology), Female, Humans, Male, Middle Aged, Propranolol (therapeutic use), Risk Factors, Sex Factors.
- MESH :
- chemical , therapeutic use : Adrenergic beta-Antagonists, Propranolol.
- drug therapy : Essential Tremor.
- epidemiology : Essential Tremor.
- physiopathology : Essential Tremor.
- Adolescent, Adult, Aged, Animals, Child, Clinical Trials as Topic, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Risk Factors, Sex Factors.
Abstract
Essential tremor (ET) is a common, often familial, movement disorder characterized by tremor of the limbs, head, and voice. Epidemiological surveys indicate that up to 5% of the adult population has ET, and 5-30% of adults with ET report symptom onset during childhood. There is, however, little published regarding ET in the pediatric population, and no prospective studies targeted specifically to children. Retrospective studies from subspecialty movement disorder clinics indicate that childhood-onset ET is usually hereditary, begins at a mean age of 6 years, and affects boys three times as often as girls. While ET occasionally results in disability during childhood, only one-quarter of children seeing a neurologist for ET require pharmacotherapy. Small case series suggest that propranolol is effective in approximately 50% of children with ET, but controlled treatment trials are lacking.
DOI: 10.2165/11316050-000000000-00000
PubMed: 19725596
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000112
- to stream PubMed, to step Curation: 000112
- to stream PubMed, to step Checkpoint: 000123
- to stream Ncbi, to step Merge: 000250
- to stream Ncbi, to step Curation: 000250
- to stream Ncbi, to step Checkpoint: 000250
- to stream Main, to step Merge: 000860
- to stream Main, to step Curation: 000849
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Epidemiology and management of essential tremor in children.</title><author><name sortKey="Ferrara, Joseph" sort="Ferrara, Joseph" uniqKey="Ferrara J" first="Joseph" last="Ferrara">Joseph Ferrara</name><affiliation wicri:level="1"><nlm:affiliation>Parkinson Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea><wicri:noRegion>Texas 77030</wicri:noRegion></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2009">2009</date><idno type="doi">10.2165/11316050-000000000-00000</idno><idno type="RBID">pubmed:19725596</idno><idno type="pmid">19725596</idno><idno type="wicri:Area/PubMed/Corpus">000112</idno><idno type="wicri:Area/PubMed/Curation">000112</idno><idno type="wicri:Area/PubMed/Checkpoint">000123</idno><idno type="wicri:Area/Ncbi/Merge">000250</idno><idno type="wicri:Area/Ncbi/Curation">000250</idno><idno type="wicri:Area/Ncbi/Checkpoint">000250</idno><idno type="wicri:doubleKey">1174-5878:2009:Ferrara J:epidemiology:and:management</idno><idno type="wicri:Area/Main/Merge">000860</idno><idno type="wicri:Area/Main/Curation">000849</idno><idno type="wicri:Area/Main/Exploration">000849</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Epidemiology and management of essential tremor in children.</title><author><name sortKey="Ferrara, Joseph" sort="Ferrara, Joseph" uniqKey="Ferrara J" first="Joseph" last="Ferrara">Joseph Ferrara</name><affiliation wicri:level="1"><nlm:affiliation>Parkinson Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Parkinson Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, Texas 77030</wicri:regionArea><wicri:noRegion>Texas 77030</wicri:noRegion></affiliation></author><author><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name><affiliation><country>États-Unis</country><placeName><settlement type="city">Houston</settlement><region type="state">Texas</region></placeName><orgName type="university" n="3">Baylor College of Medicine</orgName></affiliation></author></analytic><series><title level="j">Paediatric drugs</title><idno type="ISSN">1174-5878</idno><imprint><date when="2009" type="published">2009</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent</term><term>Adrenergic beta-Antagonists (therapeutic use)</term><term>Adult</term><term>Aged</term><term>Animals</term><term>Child</term><term>Clinical Trials as Topic</term><term>Diagnosis, Differential</term><term>Essential Tremor (drug therapy)</term><term>Essential Tremor (epidemiology)</term><term>Essential Tremor (physiopathology)</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Propranolol (therapeutic use)</term><term>Risk Factors</term><term>Sex Factors</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Adrenergic beta-Antagonists</term><term>Propranolol</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Essential Tremor</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Essential Tremor</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Essential Tremor</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adolescent</term><term>Adult</term><term>Aged</term><term>Animals</term><term>Child</term><term>Clinical Trials as Topic</term><term>Diagnosis, Differential</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Risk Factors</term><term>Sex Factors</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Essential tremor (ET) is a common, often familial, movement disorder characterized by tremor of the limbs, head, and voice. Epidemiological surveys indicate that up to 5% of the adult population has ET, and 5-30% of adults with ET report symptom onset during childhood. There is, however, little published regarding ET in the pediatric population, and no prospective studies targeted specifically to children. Retrospective studies from subspecialty movement disorder clinics indicate that childhood-onset ET is usually hereditary, begins at a mean age of 6 years, and affects boys three times as often as girls. While ET occasionally results in disability during childhood, only one-quarter of children seeing a neurologist for ET require pharmacotherapy. Small case series suggest that propranolol is effective in approximately 50% of children with ET, but controlled treatment trials are lacking.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Texas</li></region><settlement><li>Houston</li></settlement><orgName><li>Baylor College of Medicine</li></orgName></list><tree><country name="États-Unis"><noRegion><name sortKey="Ferrara, Joseph" sort="Ferrara, Joseph" uniqKey="Ferrara J" first="Joseph" last="Ferrara">Joseph Ferrara</name></noRegion><name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000849 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000849 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= JankovicV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:19725596
|texte= Epidemiology and management of essential tremor in children.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19725596" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a JankovicV1
| This area was generated with Dilib version V0.6.19. |  |